YorkBridge Wealth Partners’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-182
Closed -$9K 760
2019
Q2
$9K Buy
182
+9
+5% +$473 ﹤0.01% 600
2019
Q1
$11K Sell
173
-152
-47% -$10.4K 0.01% 587
2018
Q4
$19K Sell
325
-213
-40% -$12.8K 0.01% 480
2018
Q3
$34K Sell
538
-76
-12% -$4.24K 0.02% 405
2018
Q2
$28K Sell
614
-200
-25% -$7.97K 0.01% 450
2018
Q1
$27K Buy
814
+106
+15% +$3.49K 0.01% 456
2017
Q4
$22K Buy
708
+3
+0.4% +$87 0.01% 495
2017
Q3
$23K Buy
705
+20
+3% +$693 0.01% 492
2017
Q2
$22K Buy
685
+50
+8% +$1.49K 0.01% 493
2017
Q1
$22K Buy
+635
New +$15.7K 0.01% 495

Other funds holding BEAT

YorkBridge Wealth Partners's BEAT Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 182 shares — an estimated $9K sold.

YorkBridge Wealth Partners first reported a position in BEAT in Q1 2017 and held it in 10 quarters. The position peaked at $34K in Q3 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • YorkBridge Wealth Partners reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 182 BioTelemetry, Inc. shares in Q3 2019, an estimated $9K.
  • YorkBridge Wealth Partners first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 10 quarters.
  • YorkBridge Wealth Partners's BioTelemetry, Inc. position peaked at $34K in Q3 2018.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.